1.49
1.49 (0%)
As of Sep 06, 2023
Aziyo Biologics, Inc. [AZYO]
Source:
Company Overview
Elutia Inc. is to humanize medicine so that patients can thrive without compromise. As a commercial-stage company, we seek to leverage our unique understanding of biologics combined with local drug delivery to improve the interaction between implanted medical devices and patients by reducing complications associated with these surgeries
| Country | United States |
| Headquarters | silver spring, maryland |
| Phone Number | 240-247-1143 |
| Industry | manufacturing |
| CEO | C. Randal Mills, Ph.D. |
| Website | www.elutia.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $24.4 |
| Operating Profit | $-35.7 |
| Net Income | $-53.9 |
| Net Cash | $-6 |
Profit Ratios
| Gross Margin | $10.7 |
| Operating Margin | -146.3 |
| Profit as % of Revenues | -19.9% |
| Profit as % of Assets | -135.6% |
| Profit as % of Stockholder Equity | 116.6% |
Management Effectiveness
| Return on Equity | 116.6% |
| Return on Assets | -149.3% |
| Turnover Ratio | 61.3% |
| EBITA | $-35.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $36.1 |
| Total Liabilities | $82.4 |
| Operating Cash Flow | $-22.7 |
| Investing Cash Flow | $-0.5 |
| Financing Cash Flow | $17.1 |
